Managers / Q3 2025 · view latest →
North Peak Capital Management, LLC
CIK 0001747888 · 405 LEXINGTON AVENUE, SUITE 5001, NEW YORK, NY, 10174 · 212-209-3904
Summary
North Peak Capital Management, LLC reported $1.1B in U.S.-listed holdings across 9 positions for Q3 2025.
The portfolio is heavily concentrated: HGV alone accounts for 20.3% of reported value.
Compared with Q2 2025, the fund opened 2 new positions and exited 1.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 74.1% · $845M
- ETP · 22.8% · $261M
- Other · 3.1% · $35M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| AGILON HEALTH INC | NEW | +34.42M | 34.42M | +$35M | $35M |
| HAEHAEMONETICS CORP MASS | NEW | +362.4K | 362.4K | +$18M | $18M |
| PEGAPEGASYSTEMS INC | ADDED | +1.29M | 2.35M | +$78M | $135M |
| GLOBAL E ONLINE LTD | SOLD OUT | −2.64M | 0 | −$88M | $0 |
| DRVNDRIVEN BRANDS HLDGS INC | TRIMMED | −4.22M | 2.91M | −$78M | $47M |
| ELVELEVANCE HEALTH INC FORMERLY | TRIMMED | −148.9K | 252.8K | −$75M | $82M |
| CVNACARVANA CO | ADDED | +112.8K | 477.3K | +$57M | $180M |
| SCHWSCHWAB CHARLES CORP | TRIMMED | −501.1K | 1.59M | −$39M | $152M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2025
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | HGVHILTON GRAND VACATIONS INChistory → | COM | 20.31% | $232M | 5.54M |
| 2 | CVNACARVANA COhistory → | CL A | 15.78% | $180M | 477.3K |
| 3 | SCHWSCHWAB CHARLES CORPhistory → | COM | 13.34% | $152M | 1.59M |
| 4 | PEGAPEGASYSTEMS INChistory → | COM | 11.82% | $135M | 2.35M |
| 5 | ELVELEVANCE HEALTH INC FORMERLYhistory → | COM | 7.16% | $82M | 252.8K |
| 6 | DRVNDRIVEN BRANDS HLDGS INChistory → | COM | 4.10% | $47M | 2.91M |
| 7 | AGILON HEALTH INC | COM | 3.11% | $35M | 34.42M |
| 8 | HAEHAEMONETICS CORP MASShistory → | COM | 1.55% | $18M | 362.4K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $601M | 7 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $1.2B | 10 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $1.1B | 9 | Nov 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.3B | 8 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $996M | 8 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $755M | 7 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $711M | 7 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $851M | 8 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $900M | 8 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $952M | 9 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $812M | 8 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $872M | 6 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $780M | 5 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $678M | 4 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $647M | 5 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $713M | 6 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $725M | 7 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $921M | 6 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $778M | 8 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $516M | 4 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $452M | 5 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $559M | 9 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $525M | 9 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $454M | 9 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $208M | 11 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $370M | 11 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $233M | 10 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $178M | 10 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $155M | 10 | May 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $119M | 12 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.